Real-time enrollment status for this malignant neoplasm clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 4:03 PM UTC
| NCT Number | NCT07247110 |
| Recruiting Status | Recruiting |
| Condition | Malignant Neoplasm |
| Phase | PHASE1 |
| Target Enrollment | 250 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | September 11, 2026 (Sep 11, 2026) |
As of October 12, 2026: Clinical trial NCT07247110 is currently recruiting participants. This phase1 study for malignant neoplasm is actively seeking new participants at 3 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07247110 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07247110 was last updated Sep 11, 2026 (September 11, 2026). HelloStudys verifies this status automatically.